House Bill 9297
117th Congress(2021-2022)
Pre-Approval Information Exchange Act of 2022
Introduced
Introduced in House on Nov 15, 2022
Origin Chamber
House
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
9297
Congress
117
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
No House votes have been held for this bill.
Summary
Pre-Approval Information Exchange Act of 2022
This bill specifies that product information that is exchanged between drug manufacturers and certain health care entities (e.g., formulary committees) about drug products before regulatory approval is not considered to be misbranding if it relates to the product's investigational use and meets other specified criteria. The Government Accountability Office must study the use and effects of such information.
November 15, 2022
Sort by most recent
11/16/2022
Referred to the Subcommittee on Health.
11/15/2022
Referred to the House Committee on Energy and Commerce.
11/15/2022
Introduced in House
Public Record
Record Updated
Aug 14, 2023 9:00:32 PM